Enhancement of 5-fluorouracil cytotoxicity by cisplatin in brain tumour cell lines

Cell Biology International

Volumn 20, Issue 5, 1996, Pages 355-357

  Mineura, Katsuyoshi ^a   Kowada, Masayoshi ^a  

^a AKITA UNIVERSITY HOSPITAL   (Japan)

Author keywords

5 fluorouracil; Brain tumours; Cisplatin

Indexed keywords

CISPLATIN; FLUOROURACIL;

ANIMAL CELL; ARTICLE; BRAIN TUMOR; CELL SURVIVAL; COLONY FORMATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; DRUG RESISTANCE; DRUG SENSITIVITY; NONHUMAN; RAT; TUMOR CELL;

ANIMALIA;

EID: 0030150660     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1006/cbir.1996.0041     Document Type: Article

References (9)

1. BAJORIN DF, et al., 1993. Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study. J Clin Oncol 11: 593-595.
2. BENDA P, et al., 1968. Differentiated rat glial cell strain in tissue culture. Science 161: 370-371.
3. MAHALEY MS, 1991. Neuro-oncology index and review (adult primary brain tumors). J Neurooncol 11: 85-147.
4. OGAWA T, et al., 1993. Cerebral glioma: evaluation with methionine PET. Radiology 186: 45-53.
5. OLDENDORF WH, 1971. Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol 221: 1629-1639.
6. SCANLON KJ, et al., 1986. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci USA 83: 8923-8925.
7. SCANLON KJ, KASHANI-SABET M, 1988. Elevated expression of thymidylate synthase cycle genes in cisplatin-resistant human ovarian carcinoma A2780 cells. Proc Natl Acad Sci USA 85: 650-653.
8. SCHMIDEK HH, et al., 1971. Morphological studies of rat brain tumors induced by N-nitrosomethylurea. J Neurosurg 34: 335-340.
9. SPENCE AM, et al., 1992. Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failure. J Neurooncol 12: 187-191.